Brought to you by:
Key players behind first SVS AUC on claudication unpack details of development process
Vascular surgeons have a history of going the extra mile to do the right thing for their patients. So went the theme of one of the comments sent in near the close of a recent Society for Vascular Surgery (SVS)…
SVS publishes diversity, equity and inclusion supplement—exploring route forward
On the heels of a worldwide pandemic that has helped expose deep disparities in healthcare, the Society for Vascular Surgery (SVS) published a response—and a promise—in the form of the 2021 diversity supplement, summarizing what Society members have learned and…
Vascular surgeons as community leaders in vascular disease
Value to the healthcare system, branding and success in competing in competitive environments and ensuring optimal patient care all play a role in defining the value of vascular surgeons to both hospital leadership and patients. Richard Powell, MD, Joseph Mills,…
Learn about the JVS journals: Past, present and future
Learn how the SVS’ peer-reviewed journals, including the flagship Journal of Vascular Surgery (JVS), have evolved over the years at “Evolution and transformation of the Journal of Vascular Surgery journals.” The concurrent session will be from 1 to 2:30 p.m.…
SVS releases updated clinical practice guidelines covering carotid disease
The Society for Vascular Surgery (SVS) has released updated clinical practice guidelines accompanied by an implementation document on the management of patients with extracranial carotid artery disease. The documents, both published in the Journal of Vascular Surgery, aim to use the…
Fempop bypass shows reintervention benefit over endovascular therapy for advanced premature PAD
Femoropopliteal bypass is associated with decreased reinterventions at one year compared to endovascular therapy in patients with advanced premature peripheral arterial disease (PAD). This is the primary conclusion of Tanner I. Kim, MD, an integrated vascular surgery resident at Yale School…
The top 10 most popular Vascular Specialist stories in May
A pointed letter aimed at electronic health record (EHR) behemoth Epic, an argument in favor of endovascular treatment of ruptured abdominal aortic aneurysms (rAAAs) and the first-ever Corner Stitch column were among the best-read stories here on the Vascular Specialist…
One-year results from PROMISE I study of LimFlow system in ‘no-option’ CLTI patients published
Twelve-month data from the full patient cohort in the PROMISE I study of the LimFlow percutaneous deep vein arterialization (pDVA) system have been published in the Journal of Vascular Surgery. Results showed sustained positive outcomes for both amputation-free survival and…
Interventions associated with ‘poor’ two-year relief of intermittent claudication symptoms
Peripheral vascular interventions for intermittent claudication were linked to “poor” two-year relief of symptoms in the Vascular Quality Initiative (VQI) database, a new study published in the May issue of the Journal of Vascular Surgery (JVS) found. First-named author Jonathan…
VAM: Session on diversity set to feature on Friday of SVS annual meeting
Racial and ethnically based disparities exist in healthcare. To highlight these disparities, and what the Society for Vascular Surgery (SVS) is doing to address them, the 2021 Vascular Annual Meeting (VAM) will feature a special session on diversity, equity and…